Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab
Clinical trial NCT01927757 · TERMINATED
Trial details
- NCT number
- NCT01927757
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-06
- Primary completion
- 2015-06-11
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.